A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin Before
Clinical trial NCT04460885 · COMPLETED
Trial details
- NCT number
- NCT04460885
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-25
- Primary completion
- 2022-05-29
- Enrollment
- 984
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.